Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billio...
) are also investing in gene therapy manufacturing, according to a Reuters analysis of public filings and executive interviews.
One of the former executives, Brian Kaspar, denied wrongdoing in a statement to Reuters. Another, his brother Allan Kaspar, could not be reached for comment. According to four of them, the FDA has stressed in recent meetings the need for continuity in production processes all the way from the development of a drug to its commercialization.
“Manufacturing consistency is always a major concern for the agency,” FDA spokeswoman Stephanie Caccomo told Reuters.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer, Novartis lead pharma spending spree on gene therapy productionEleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billio...
Lire la suite »
Pfizer, Novartis lead pharma spending spree on gene therapy productionEleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billio...
Lire la suite »
Aramco IPO retail subscription at $7.21 billion: lead managerRetail subscription for Saudi Aramco's initial public offering (IPO) reache...
Lire la suite »
Dopamine’s ‘Hernán’ Sets New Standards of Hispanic TV AmbitionMADRID — A leading example of transatlantic Spanish-language co-production, historical drama “Hernán” – co-produced by Mexico’s Dopamine, part of Mexico’s Salinas Group in collaboration with …
Lire la suite »
You can now buy 23andMe genetic tests and gluten sensors with FSA moneyThe clock is ticking and there's only a month left to spend your FSA. Here are 3 popular items to spend your tax-free dollars on:
Lire la suite »